Melanoma
Showing all 13 results
-
BIMZELX (bimekizumab-bkzx) injection
Read more -
COTELLIC (cobimetinib) tablets. FDA-Approved
Read more -
IMLYGIC (talimogene laherparepvec). Suspension for intralesional injection Initial U.S. Approval: 2015
Read more -
KEYTRUDA (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014
Read more -
LIBTAYO (cemiplimab-rwlc) injection, for intravenous use. Initial U.S. Approval: 09/2018
Read more -
MEKINIST (trametinib) tablets, for oral use. Initial U.S. Approval: 2013
Read more -
OPDUALAG (nivolumab and relatlimab-rmbw) injection
Read more -
SOTYKTU (deucravacitinib) tablets
Read more -
SPEVIGO (spesolimab-sbzo) injection
Read more -
TAFINLAR (dabrafenib) capsules, for oral use. Initial U.S. Approval: 2013
Read more -
YERVOY (ipilimumab) injection, for intravenous use. Initial U.S. Approval: 2011
Read more -
ZELBORAF (vemurafenib) tablet. FDA-Approved
Read more -
ZYNYZ (retifanlimab-dlwr) injection
Read more
